Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). more
| Time Frame | XBI | S&P500 |
|---|---|---|
| 1-Week Return | 7.13% | 3.24% |
| 1-Month Return | 11.66% | 4.53% |
| 3-Month Return | 10.68% | 3.48% |
| 6-Month Return | 28.64% | 5.58% |
| 1-Year Return | 82.63% | 33.26% |
| 3-Year Return | 69.46% | 69.58% |
| 5-Year Return | 7.73% | 68.93% |
| 10-Year Return | 141.71% | 235.97% |
| Time Frame | XBI | S&P500 |
|---|---|---|
| 1-Week Return | 3,527.86% | 427.32% |
| 1-Month Return | 282.61% | 71.43% |
| 3-Month Return | 50.91% | 14.88% |
| 6-Month Return | 66.64% | 11.64% |
| 1-Year Return | 82.63% | 33.26% |
| 3-Year Return | 19.22% | 19.25% |
| 5-Year Return | 1.50% | 11.06% |
| 10-Year Return | 9.23% | 12.88% |
| Stock name | Ticker | Weight |
|---|---|---|
Apellis Pharmaceuticals Inc | APLS | 1.8% |
Revolution Medicines Inc | RVMD | 1.51% |
Alkermes Plc | ALKS | 1.34% |
Madrigal Pharmaceuticals Inc | MDGL | 1.34% |
TG Therapeutics Inc | TGTX | 1.33% |
Apogee Therapeutics, Inc. Common Stock | APGE | 1.28% |
Summit Therapeutics PLC | SMMT | 1.27% |
Beam Therapeutics Inc | BEAM | 1.27% |
Scholar Rock Holding Corp | SRRK | 1.26% |
Crispr Therapeutics AG | CRSP | 1.21% |
| Sector | Weight |
|---|---|
|
Health care | 99.82% |
|
Financials | 0.18% |
SPDR® S&P Biotech ETF (XBI) share price today is $138.67.
Yes, Indians can buy shares of SPDR® S&P Biotech ETF (XBI) on Vested. To buy XBI from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of SPDR® S&P Biotech ETF (XBI) on Vested. You can start investing in SPDR® S&P Biotech ETF (XBI) with a minimum investment of $1.
The 52-week high price of SPDR® S&P Biotech ETF (XBI) is $137.5. The 52-week low price of SPDR® S&P Biotech ETF (XBI) is $74.4.
The stock symbol (or ticker) of SPDR® S&P Biotech ETF is XBI.
Yes, you can setup SIP in SPDR® S&P Biotech ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of XBI on the Vested app.
The expense ratio of SPDR® S&P Biotech ETF (XBI) is 0.35%.
Link copied